SUPERNUS PHARMACEUTICALS, INC. financial data

Symbol
SUPN on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 215% % 5.6%
Quick Ratio 25% % 17%
Debt-to-equity 33% % -6.9%
Return On Equity -3.7% % -149%
Return On Assets -2.8% % -150%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57,581,712 shares 2.8%
Common Stock, Shares, Outstanding 57,457,462 shares 3.1%
Entity Public Float $1,694,871,061 USD 20%
Common Stock, Value, Issued $57,000 USD 1.8%
Weighted Average Number of Shares Outstanding, Basic 56,451,136 shares 2.5%
Weighted Average Number of Shares Outstanding, Diluted 56,451,136 shares 0.88%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $718,952,000 USD 8.6%
Research and Development Expense $106,235,000 USD -2.4%
Costs and Expenses $781,235,000 USD 35%
Operating Income (Loss) $62,283,000 USD -176%
Nonoperating Income (Expense) $13,253,000 USD -18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $49,030,000 USD -150%
Income Tax Expense (Benefit) $10,480,000 USD -144%
Net Income (Loss) Attributable to Parent $38,550,000 USD -152%
Earnings Per Share, Basic -0.68 USD/shares -151%
Earnings Per Share, Diluted -0.68 USD/shares -152%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $128,448,000 USD 85%
Accounts Receivable, after Allowance for Credit Loss, Current $187,802,000 USD 32%
Inventory, Net $112,480,000 USD 107%
Assets, Current $644,182,000 USD -6.1%
Deferred Income Tax Assets, Net $38,351,000 USD
Property, Plant and Equipment, Net $10,531,000 USD -8.8%
Operating Lease, Right-of-Use Asset $26,712,000 USD 9.1%
Intangible Assets, Net (Excluding Goodwill) $569,456,000 USD 9.1%
Goodwill $124,882,000 USD 6.7%
Other Assets, Noncurrent $63,796,000 USD 102%
Assets $1,452,648,000 USD 6.2%
Accounts Payable, Current $2,677,000 USD -42%
Employee-related Liabilities, Current $29,446,000 USD 39%
Accrued Liabilities, Current $107,800,000 USD 41%
Liabilities, Current $338,171,000 USD 16%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $30,365,000 USD 11%
Other Liabilities, Noncurrent $22,192,000 USD 192%
Liabilities $390,934,000 USD 18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $44,000 USD 77%
Retained Earnings (Accumulated Deficit) $517,876,000 USD -6.9%
Stockholders' Equity Attributable to Parent $1,061,714,000 USD 2.5%
Liabilities and Equity $1,452,648,000 USD 6.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $30,599,000 USD -20%
Net Cash Provided by (Used in) Financing Activities $21,399,000 USD -1463%
Net Cash Provided by (Used in) Investing Activities $37,317,000 USD
Common Stock, Shares Authorized 130,000,000 shares 0%
Common Stock, Shares, Issued 57,457,462 shares 3.1%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $46,517,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $129,898,000 USD 87%
Deferred Tax Assets, Valuation Allowance $590,223,000 USD 785%
Deferred Tax Assets, Gross $790,078,000 USD 296%
Operating Lease, Liability $40,977,000 USD 20%
Payments to Acquire Property, Plant, and Equipment $327,000 USD 32%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $38,405,000 USD -152%
Lessee, Operating Lease, Liability, to be Paid $46,998,000 USD 18%
Property, Plant and Equipment, Gross $28,795,000 USD -2%
Operating Lease, Liability, Current $10,612,000 USD 54%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,198,000 USD 3.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,413,000 USD 51%
Operating Lease, Weighted Average Discount Rate, Percent 0.053 pure 8.2%
Deferred Income Tax Expense (Benefit) $3,990,000 USD 27%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,021,000 USD 5.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,547,000 USD 38%
Deferred Tax Assets, Operating Loss Carryforwards $571,102,000 USD 513%
Unrecognized Tax Benefits $13,991,000 USD 140%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,296,000 USD 110%
Operating Lease, Payments $3,892,000 USD -2.7%
Additional Paid in Capital $543,825,000 USD 13%
Amortization of Intangible Assets $89,456,000 USD 15%
Depreciation, Depletion and Amortization $20,383,000 USD -1.8%
Deferred Tax Assets, Net of Valuation Allowance $199,855,000 USD 51%
Share-based Payment Arrangement, Expense $55,972,000 USD 102%
Interest Expense $0 USD -100%